You have 9 free searches left this month | for more free features.

Condition

COVID-19 (1)

Covid19 (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Eli Lilly and Company (1)

University of Liverpool (1)

Collaborator

AbCellera Biologics Inc. (1)

GlaxoSmithKline (1)

Liverpool School of Tropical Medicine (1)

Liverpool University Hospitals NHS Foundation Trust (1)

Shanghai Junshi Bioscience Co., Ltd. (1)

University of Cambridge (1)

University of Southampton (1)

Vir Biotechnology, Inc. (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

vir-7831

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)

Recruiting

Covid19

CST-2: EIDD-2801
+6 more

Cape Town, South Africa
+5 more

Aug 9, 2022

COVID-19 Trial in Argentina, Puerto Rico, United States (Bamlanivimab, Etesevimab, Placebo)

Completed

Has Results

COVID-19

Bamlanivimab
+4 more

Birmingham, Alabama
+140 more

Jun 7, 2022